share_log

和鉑醫藥-B：自願公佈 - 執行董事自願禁售承諾

HBM HOLDINGS-B: VOLUNTARY ANNOUNCEMENT - VOLUNTARY LOCK-UP UNDERTAKING BY EXECUTIVE DIRECTOR

Hong Kong Stock Exchange ·  Apr 17 04:30
Summary by Moomoo AI
和鉑醫藥控股有限公司（「和鉑醫藥-B」）於2024年4月17日宣佈，執行董事、行政總裁兼董事會主席王勁松博士自願承諾在至少六個月內不會出售其直接或間接持有的公司股份。此舉顯示王勁松對和鉑醫藥的未來前景及長遠發展持樂觀態度。
和鉑醫藥控股有限公司（「和鉑醫藥-B」）於2024年4月17日宣佈，執行董事、行政總裁兼董事會主席王勁松博士自願承諾在至少六個月內不會出售其直接或間接持有的公司股份。此舉顯示王勁松對和鉑醫藥的未來前景及長遠發展持樂觀態度。
WO PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (“WA PLATINUM PHARMACEUTICAL-B”) ANNOUNCED ON 17 APRIL 2024 THAT ITS EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD OF DIRECTORS, DR. WANG JINSONG VOLUNTARILY UNDERTOOK NOT TO SELL SHARES OF HIS DIRECTLY OR INDIRECTLY HELD COMPANY FOR AT LEAST SIX MONTHS. This move shows that Wang Jinsong is optimistic about the future prospects and long-term development of platinum medicine.
WO PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (“WA PLATINUM PHARMACEUTICAL-B”) ANNOUNCED ON 17 APRIL 2024 THAT ITS EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD OF DIRECTORS, DR. WANG JINSONG VOLUNTARILY UNDERTOOK NOT TO SELL SHARES OF HIS DIRECTLY OR INDIRECTLY HELD COMPANY FOR AT LEAST SIX MONTHS. This move shows that Wang Jinsong is optimistic about the future prospects and long-term development of platinum medicine.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more